Immuno-Oncology Resource Center

Immuno-Oncology Resource Center

Source:

Press Release

October 31, 2021
1 min read
Save

Society announces inaugural fellows class for Academy of Immuno-Oncology

Source:

Press Release

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The Society for Immunotherapy of Cancer announced the inaugural class of Fellows of the Academy of Immuno-Oncology.

The society established the academy to honor individuals who helped cancer immunotherapy become a breakthrough cancer treatment.

James Allison, PhD
James P. Allison

The inaugural fellows class will be honored at the society’s annual meeting, scheduled for Nov. 10-14 in Washington, D.C. SITC plans to induct a new class of fellows each year, with the next round of nominations scheduled for spring of 2022.

Photo of Elizabeth Jaffee
Elizabeth M. Jaffee

This year’s fellows are James P. Allison, PhD, of The University of Texas MD Anderson Cancer Center; Lieping Chen, MD, PhD, of Yale School of Medicine; Zelig Eshhar, PhD, of Weizmann Institute of Science and the Tel Aviv Sourasky Medical Center; Gordon J. Freeman, PhD, of Dana-Farber Cancer Institute; Philip D. Greenberg, MD, of Fred Hutchinson Cancer Research Center; Tasuku Honjo, MD, PhD, of Kyoto University Graduate School of Medicine; Elizabeth M. Jaffee, MD, of Sidney Kimmel Cancer Center at Johns Hopkins University; Carl H. June, MD, of University of Pennsylvania; Alan J. Korman, PhD, of Vir Biotechnology; Margaret L. Kripke, PhD, of The University of Texas MD Anderson Cancer Center; Ronald Levy, MD, of Stanford University; Steven A. Rosenberg, MD, PhD, of NCI/NIH; Robert D. Schreiber, PhD, of Washington University School of Medicine; Arlene H. Sharpe, MD, PhD, of Harvard Medical School; and Thomas A. Waldmann, MD, of NCI/NIH (posthumous).